India’s 1st Homemade Pneumonia Vaccine

• 18 Jul 2020

• The Drug Controller General of India (DCGI) has given its nod of approval for India's first indigenously developed vaccine against pneumonia. The vaccine has been developed and manufactured by the Serum Institute of India, Pune.
• The Pneumococcal Polysaccharide Conjugate Vaccine (PPSV23) offers protection against 23 types of pneumonia-causing bacteria, which cause a range of infections including meningitis, bacteremia, pneumonia and blood infections.
• Serum Institute conducted Phase I, Phase II and Phase III clinical trials of the Pneumococcal Polysaccharide Conjugate Vaccine in India and was successful. They also undertook clinical trials in the West African nation of The Gambia.